IO Biotech Competitors and Similar CompaniesClear all

IO Biotech's competitors and similar companies include Cullgen, AgomAb Therapeutics, SEEKYO and Core Biogenesis.

	IO Biotech IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies.	Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.	AgomAb Therapeutics AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues.	SEEKYO SEEKYO is a biotech company that provides chemotherapies without adverse effects.	Core Biogenesis Core Biogenesis is a biotech company developing a production platform to express recombinant proteins from plants.
Founding Date	Founding Date 2014	Founding Date 2018	Founding Date 2017	Founding Date 2018	Founding Date 2020
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Technology biotech drug development oncology therapy	Tags Technology biotech drug development oncology pharma therapy	Tags Technology biotech drug development oncology therapy	Tags Technology biotech drug development oncology therapy	Tags Technology biotech drug development oncology pharma therapy
Locations	Locations New York, US HQ København, DK Usk, GB Rockville, US	Locations San Diego, US HQ Shanghai, CN Tokyo, JP	Locations Antwerpen, BE HQ Gent, BE	Locations Poitiers, FR HQ Chasseneuil Du Poitou, FR	Locations Paris, FR HQ Illkirch Graffenstaden, FR
Employees	Employees 19	Employees 4	Employees 62	Employees 833% increase	Employees 293% decrease
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 16m (about 7 years ago)	Latest funding round N/A	Latest funding round $ 720.5k (over 6 years ago)	Latest funding round $ 11m (about 4 years ago)
Total funding raised	Total funding raised $ 165.9m	Total funding raised $ 31m	Total funding raised $ 97.6m	Total funding raised $ 720.5k	Total funding raised $ 14.1m